drugset / Trial / NCT01439555

Endothelial Facilitation in Alzheimer's Disease

NCT01439555

NaSingle-groupOpen-labelTreatment

Summary

Purpose of the study: Patients with mild Alzheimer's Disease will be given three different drugs over a 4-month period to try to increase the blood flow to their brains, and improve blood vessel and brain function. Each drug can help to open the blood vessels in the brain, and together they may be more effective than each drug alone. The hypothesis is that small blood vessels secrete substances that maintain the integrity of the brain, and may prevent loss of nerve cells leading to Alzheimer's Disease

Timeline

Start
2011-11
Primary completion
2017-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 2 g Oral
Subject Simvastatin Small molecule 40 mg Oral
Subject sapropterin Unknown 20 mg/kg Oral

Indications